Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 29% · prior close shown (market closed)
Limited proprietary earnings coverage for TECH yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for BIO-TECHNE Corp — research only, not investment advice.
Theme: Diagnostics & Spatial Biology Divestiture
Updated
What happened recently for BIO-TECHNE Corp (TECH) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$72.17
Market cap
$11.30B
Profitable
Yes
Revenue $311.42M
Net income
$51.05M
FY Jul 27, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for BIO-TECHNE Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow BIO-TECHNE Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.